-+ 0.00%
-+ 0.00%
-+ 0.00%

Maravai LifeSciences Sees FY2026 Sales $200.000M-$210.000M vs $203.430M Est

Benzinga·02/25/2026 21:08:35
Listen to the news
Maravai LifeSciences (NASDAQ:MRVI) sees FY2026 sales of $200.000 million-$210.000 million vs $203.430 million analyst estimate.